Skip to content
Politically.com Search all
Menu

2025 · 3rd Quarter (July 1 - Sep 30)

ORCHARD THERAPEUTICS NORTH AMERICA

Filed by LEAVITT PARTNERS, LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 20, 2025
Income
$20,000.00
Expenses
Not reported
Filing UUID
5e697534-95fd-4065-8281-686e5ef1029a
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Newborn screening and pharmaceuticals. The Accelerating Kids Access to Care Act (H.R. 1509/S. 752).

Literal federal measure citations: H.R. 1509, S. 752

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.